AKT1 and rheumatoid arthritis: Several studies have shown that tetrandrine and fangchinoline can regulate RA to some extent through their effects on the PI3K/Akt signaling pathway (Yang et al., 2020; Xu et al., 2021; Zhang et al., 2021; Shao et al., 2022).